hit counter
Bio-Rad Laboratories, Inc. (BIO) Stock News Sentiment & Price - Sentifly
BIO - Sentifly



Your watchlist is empty. Go add some tickers to it!

Bio-Rad Laboratories, Inc. (BIO)

Medical Laboratories & Research
BIO Price and Sentiment
Positive, Negative
Loading chart...
BIO Latest news
Zacks Investment Research
Recent Price Trend in Bio-Rad (BIO) is Your Friend, Here's Why
2021-11-04 09:57

If you are looking for stocks that are well positioned to maintain their recent uptrend, Bio-Rad (BIO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Investment Research
Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised
2021-10-29 12:14

Strength in the Life Science and Clinical Diagnostics segments drove Bio-Rad's (BIO) revenues in the third quarter.

Seeking Alpha
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call Transcript
2021-10-28 21:53

Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings and Revenue Estimates
2021-10-28 19:06

Bio-Rad (BIO) delivered earnings and revenue surprises of 61.30% and 11.33%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Business Wire
Bio-Rad Reports Third-Quarter 2021 Financial Results
2021-10-28 16:15

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2021. Third-quarter 2021 net sales were $747.0 million, an increase of 15.4 percent compared to $647.3 million reported for the third quarter of 2020. On a currency-neutral basis, quarterly sales increased 13.8 percent compared to the same period in 2020. Third-qu

9 Moonshot Bets to Beat Hedge Funds at Their Own Game
2021-10-22 16:59

Beating the market is hard, but it can be made easier by using the right set of tools. Here are the metrics to analyze penny stocks.

Zacks Investment Research
Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards?
2021-10-22 12:49

Recovery in Clinical Diagnostics arm and strong growth in Droplet Digital PCR platform are expected to have contributed to Bio-Rad's (BIO) Q3 results.

Which Stocks Are More Attractive Than eBay's Stock?
2021-10-22 05:00

We believe that there are other stocks that are currently better valued than eBay's stock. EBAY's current price-to-operating income ratio (P/EBIT) of 16.7x is higher than levels of 13.3x for PerkinElmer, 10.7x for AGCO, 6.27x for Dish Network, 5.45x for Lennar and 5.45x for Bio-Rad Laboratories.

Zacks Investment Research
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
2021-10-21 17:24

Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research
Here's Why You Should Retain Bio-Rad (BIO) Stock For Now
2021-10-20 11:40

Investors are optimistic about Bio-Rad (BIO) on solid international market performance and raised 2021 guidance.

Loading more news...